{
    "nctId": "NCT01082549",
    "title": "Randomized Phase 3 Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)",
    "symPyJSON": {
        "type": "and",
        "operands": [
            {
                "type": "and",
                "operands": [
                    {
                        "type": "variable",
                        "value": "Newly diagnosed, stage IV squamous cell lung cancer. This includes patients who present with disseminated metastases, and those with a malignant pleural or pericardial effusion (i.e., formerly stage IIIB in the 6th TNM staging system)."
                    },
                    {
                        "type": "implies",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Patients have received prior adjuvant therapy for early-stage lung cancer"
                            },
                            {
                                "type": "variable",
                                "value": "at least 12 months have elapsed from that treatment"
                            }
                        ]
                    },
                    {
                        "type": "variable",
                        "value": "Histologically confirmed squamous cell bronchogenic carcinoma"
                    },
                    {
                        "type": "variable",
                        "value": "Tumors contain mixed non-small cell histologies as long as squamous carcinoma is the predominant histology"
                    },
                    {
                        "type": "variable",
                        "value": "Cytologic specimens obtained by brushings, washings, or needle aspiration of the defined lesion are acceptable"
                    },
                    {
                        "type": "implies",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Patients have had previous radiotherapy as definitive therapy for locally advanced non-small cell lung cancer"
                            },
                            {
                                "type": "variable",
                                "value": "The recurrence is outside the original radiation therapy port"
                            }
                        ]
                    },
                    {
                        "type": "implies",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Patients have received chemo/radiation for locally advanced NSCLC"
                            },
                            {
                                "type": "variable",
                                "value": "Radiation therapy completed >4 weeks prior to the initiation of study treatment"
                            }
                        ]
                    },
                    {
                        "type": "implies",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Patients have received palliative radiation therapy for symptomatic metastases"
                            },
                            {
                                "type": "variable",
                                "value": "completed treatment >14 days prior the initiation of the study treatment"
                            }
                        ]
                    },
                    {
                        "type": "variable",
                        "value": "Presence of evaluable (measurable or non-measurable) disease"
                    },
                    {
                        "type": "variable",
                        "value": "ECOG Performance Status of 0 or 1"
                    },
                    {
                        "type": "variable",
                        "value": "Absolute neutrophil count (ANC) >1,500/microL and platelets >100,000/microL (\u226472 hours prior to initial treatment)"
                    },
                    {
                        "type": "variable",
                        "value": "Hemoglobin >9 g/dL (Note: Patients may be transfused or receive erythropoietin to maintain or exceed this level)"
                    },
                    {
                        "type": "variable",
                        "value": "Bilirubin < ULN"
                    },
                    {
                        "type": "variable",
                        "value": "Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) \u22642.5 times the upper limit of normal if no liver involvement or \u22645 times the upper limit of normal with liver involvement"
                    },
                    {
                        "type": "variable",
                        "value": "Creatinine <2.0 mg/dL, or creatinine clearance >40 mL/min (as calculated by the Cockcroft-Gault method)"
                    },
                    {
                        "type": "implies",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Women of childbearing potential"
                            },
                            {
                                "type": "and",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "negative serum pregnancy test performed within 7 days prior to start of treatment"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "must use effective birth control measures during treatment and at least 6 months after the last dose of the study treatment"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "inform treating physician immediately if becomes pregnant or suspects she is pregnant while participating in this study"
                                    }
                                ]
                            }
                        ]
                    },
                    {
                        "type": "variable",
                        "value": "Sexually active men must agree to use a medically acceptable form of birth control during treatment and at least 6 months after the last dose"
                    },
                    {
                        "type": "variable",
                        "value": "inform treating physician if a female partner becomes pregnant during the course of the study"
                    },
                    {
                        "type": "variable",
                        "value": ">18 years of age"
                    },
                    {
                        "type": "variable",
                        "value": "Ability to understand the nature of this study, give written informed consent, and comply with study requirements"
                    },
                    {
                        "type": "implies",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Patients entering this study must be willing to provide tissue from a previous tumor biopsy for correlative testing"
                            },
                            {
                                "type": "and",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "An exception to this is when the national/local regulations prohibit some of the key activities of this research like the export of samples to third countries, storage of coded samples or global gene expression profiling without a pre-specified list of target genes"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "If tissue is not available, a patient will still be eligible for enrollment into the study"
                                    }
                                ]
                            }
                        ]
                    }
                ]
            },
            {
                "type": "not",
                "operands": [
                    {
                        "type": "or",
                        "operands": [
                            {
                                "type": "variable",
                                "value": "Prior treatment with gemcitabine, carboplatin (except in the adjuvant setting), or Iniparib"
                            },
                            {
                                "type": "implies",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "Past or current history of neoplasm other than the entry diagnosis"
                                    },
                                    {
                                        "type": "or",
                                        "operands": [
                                            {
                                                "type": "variable",
                                                "value": "treated non-melanoma skin cancer"
                                            },
                                            {
                                                "type": "variable",
                                                "value": "treated carcinoma in-situ of any primary site"
                                            },
                                            {
                                                "type": "and",
                                                "operands": [
                                                    {
                                                        "type": "variable",
                                                        "value": "invasive cancers treated definitively"
                                                    },
                                                    {
                                                        "type": "variable",
                                                        "value": "treatment ending >5 years previously and no evidence of recurrences"
                                                    }
                                                ]
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "type": "or",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "Malignant hypertension"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "Unstable angina"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "Congestive heart failure"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "Myocardial infarction within the previous 6 months"
                                    },
                                    {
                                        "type": "implies",
                                        "operands": [
                                            {
                                                "type": "variable",
                                                "value": "Symptomatic, unstable or uncontrolled, cardiac arrhythmias"
                                            },
                                            {
                                                "type": "variable",
                                                "value": "Patients have stable, rate-controlled atrial fibrillation"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "type": "variable",
                                "value": "Active brain metastases"
                            },
                            {
                                "type": "implies",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "Patients with treated brain metastases are eligible"
                                    },
                                    {
                                        "type": "and",
                                        "operands": [
                                            {
                                                "type": "variable",
                                                "value": "radiation therapy was completed at least 2 weeks prior to study entry"
                                            },
                                            {
                                                "type": "variable",
                                                "value": "follow-up scan shows no disease progression"
                                            },
                                            {
                                                "type": "variable",
                                                "value": "patient does not require steroids"
                                            }
                                        ]
                                    }
                                ]
                            },
                            {
                                "type": "variable",
                                "value": "Women who are pregnant or lactating"
                            },
                            {
                                "type": "variable",
                                "value": "Any serious, active infection (> Grade 2) at the time of treatment"
                            },
                            {
                                "type": "variable",
                                "value": "A serious underlying medical condition that would impair the ability of the patient to receive protocol treatment"
                            },
                            {
                                "type": "or",
                                "operands": [
                                    {
                                        "type": "variable",
                                        "value": "A major surgical procedure \u226428 days of beginning treatment"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "significant traumatic injury \u226428 days of beginning treatment"
                                    },
                                    {
                                        "type": "variable",
                                        "value": "anticipation of the need for major surgery during the course of the study"
                                    }
                                ]
                            },
                            {
                                "type": "variable",
                                "value": "Uncontrolled or intercurrent illness including, that in the opinion of the investigator may increase the risks associated with study participation or administration of the investigational products, or that may interfere with the interpretation of the results"
                            },
                            {
                                "type": "variable",
                                "value": "History of any medical or psychiatric condition or laboratory abnormality that, in the opinion of the investigator, may increase the risks associated with the study participation or administration of the investigational products, or that may interfere with the interpretation of the results"
                            },
                            {
                                "type": "variable",
                                "value": "Known or suspected allergy/hypersensitivity to any agent given in the course of this trial"
                            }
                        ]
                    }
                ]
            }
        ]
    },
    "symPyExpression": "And(Symbol('>18 years of age'), Symbol('Ability to understand the nature of this study, give written informed consent, and comply with study requirements'), Symbol('Absolute neutrophil count (ANC) >1,500/microL and platelets >100,000/microL (\u226472 hours prior to initial treatment)'), Symbol('Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) \u22642.5 times the upper limit of normal if no liver involvement or \u22645 times the upper limit of normal with liver involvement'), Symbol('Bilirubin < ULN'), Symbol('Creatinine <2.0 mg/dL, or creatinine clearance >40 mL/min (as calculated by the Cockcroft-Gault method)'), Symbol('Cytologic specimens obtained by brushings, washings, or needle aspiration of the defined lesion are acceptable'), Symbol('ECOG Performance Status of 0 or 1'), Symbol('Hemoglobin >9 g/dL (Note: Patients may be transfused or receive erythropoietin to maintain or exceed this level)'), Symbol('Histologically confirmed squamous cell bronchogenic carcinoma'), Symbol('Newly diagnosed, stage IV squamous cell lung cancer. This includes patients who present with disseminated metastases, and those with a malignant pleural or pericardial effusion (i.e., formerly stage IIIB in the 6th TNM staging system).'), Symbol('Presence of evaluable (measurable or non-measurable) disease'), Symbol('Sexually active men must agree to use a medically acceptable form of birth control during treatment and at least 6 months after the last dose'), Symbol('Tumors contain mixed non-small cell histologies as long as squamous carcinoma is the predominant histology'), Symbol('inform treating physician if a female partner becomes pregnant during the course of the study'), Implies(Symbol('Patients have had previous radiotherapy as definitive therapy for locally advanced non-small cell lung cancer'), Symbol('The recurrence is outside the original radiation therapy port')), Implies(Symbol('Patients have received chemo/radiation for locally advanced NSCLC'), Symbol('Radiation therapy completed >4 weeks prior to the initiation of study treatment')), Implies(Symbol('Patients have received palliative radiation therapy for symptomatic metastases'), Symbol('completed treatment >14 days prior the initiation of the study treatment')), Implies(Symbol('Patients have received prior adjuvant therapy for early-stage lung cancer'), Symbol('at least 12 months have elapsed from that treatment')), Implies(Symbol('Patients entering this study must be willing to provide tissue from a previous tumor biopsy for correlative testing'), And(Symbol('An exception to this is when the national/local regulations prohibit some of the key activities of this research like the export of samples to third countries, storage of coded samples or global gene expression profiling without a pre-specified list of target genes'), Symbol('If tissue is not available, a patient will still be eligible for enrollment into the study'))), Implies(Symbol('Women of childbearing potential'), And(Symbol('inform treating physician immediately if becomes pregnant or suspects she is pregnant while participating in this study'), Symbol('must use effective birth control measures during treatment and at least 6 months after the last dose of the study treatment'), Symbol('negative serum pregnancy test performed within 7 days prior to start of treatment'))), Not(Or(Symbol('A major surgical procedure \u226428 days of beginning treatment'), Symbol('A serious underlying medical condition that would impair the ability of the patient to receive protocol treatment'), Symbol('Active brain metastases'), Symbol('Any serious, active infection (> Grade 2) at the time of treatment'), Symbol('Congestive heart failure'), Symbol('History of any medical or psychiatric condition or laboratory abnormality that, in the opinion of the investigator, may increase the risks associated with the study participation or administration of the investigational products, or that may interfere with the interpretation of the results'), Symbol('Known or suspected allergy/hypersensitivity to any agent given in the course of this trial'), Symbol('Malignant hypertension'), Symbol('Myocardial infarction within the previous 6 months'), Symbol('Prior treatment with gemcitabine, carboplatin (except in the adjuvant setting), or Iniparib'), Symbol('Uncontrolled or intercurrent illness including, that in the opinion of the investigator may increase the risks associated with study participation or administration of the investigational products, or that may interfere with the interpretation of the results'), Symbol('Unstable angina'), Symbol('Women who are pregnant or lactating'), Symbol('anticipation of the need for major surgery during the course of the study'), Symbol('significant traumatic injury \u226428 days of beginning treatment'), Implies(Symbol('Symptomatic, unstable or uncontrolled, cardiac arrhythmias'), Symbol('Patients have stable, rate-controlled atrial fibrillation')), Implies(Symbol('Patients with treated brain metastases are eligible'), And(Symbol('follow-up scan shows no disease progression'), Symbol('patient does not require steroids'), Symbol('radiation therapy was completed at least 2 weeks prior to study entry'))), Implies(Symbol('Past or current history of neoplasm other than the entry diagnosis'), Or(Symbol('treated carcinoma in-situ of any primary site'), Symbol('treated non-melanoma skin cancer'), And(Symbol('invasive cancers treated definitively'), Symbol('treatment ending >5 years previously and no evidence of recurrences')))))))"
}